X4 PHARMACEUTICALS, INC

Profile

Company Names

X4 PHARMACEUTICALS, INC
ARSANIS, INC.

Addresses

61 NORTH BEACON STREET, 4TH FLOOR, BOSTON, MA 02134

890 WINTER STREET, SUITE 230, WALTHAM, MA 02451

890 WINTER STREET, SUITE 230, WALTHAM, MA 02451

7 LUCENT DRIVE, LEBANON, NH 03766

16 CAVENDISH COURT, LEBANON, NH 03766

Phone Numbers

857-529-8300
781-819-5704
603-727-7107

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2010

State Incorporated:

DELAWARE

Total Amount Raised:

$320,311,984.00

Number of Funding Rounds:

10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2025-08-13 
$84,999,985.00 
$84,999,985.00 
$0.00 
Equity 
9
2023-05-18 
$65,015,462.00 
$65,023,725.00 
$8,263.00 
Equity 
8
2022-07-06 
$55,749,999.00 
$111,526,550.00 
$55,776,551.00 
Equity 
7
2017-11-20 
$20,000,000.00 
$20,000,000.00 
$0.00 
Equity 
6
2017-04-24 
$45,539,314.00 
$50,539,341.00 
$5,000,027.00 
Equity 
5
2016-04-12 
$15,007,220.00 
$15,007,220.00 
$0.00 
Equity, Debt 
4
2015-12-16 
$4,000,000.00 
$4,000,000.00 
$0.00 
Debt 
3
2013-07-30 
$20,000,000.00 
$20,000,000.00 
$0.00 
Equity 
2
2011-01-31 
$9,600,002.00 
$9,600,002.00 
$0.00 
Equity 
1
2010-09-15 
$400,002.00 
$400,002.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JAN 
 
ADAMS 
DIRECTOR
WILLIAM 
E. 
ALISKI 
DIRECTOR
ERRIK 
ANDERSON 
EXECUTIVE OFFICER, DIRECTOR
ERRIK 
B. 
ANDERSON 
EXECUTIVE OFFICER, DIRECTOR
CHRISTOPHE 
 
ARBET-ENGELS 
EXECUTIVE OFFICER
MARK 
 
BALDRY 
EXECUTIVE OFFICER
ROBERT 
L. 
BIRNBAUM 
EXECUTIVE OFFICER
GARY 
 
BRIDGER 
DIRECTOR
GARY 
J. 
BRIDGER 
DIRECTOR
DAN 
 
BURGESS 
DIRECTOR
DANIEL 
 
BURGESS 
DIRECTOR
DIEGO 
 
CADAVID 
EXECUTIVE OFFICER
ADAM 
 
CRAIG 
EXECUTIVE OFFICER, DIRECTOR
FRANCOISE 
 
DE CRAECKER 
DIRECTOR
MARY 
 
DIBIASE 
EXECUTIVE OFFICER
TILLMAN 
 
GERNGROSS 
EXECUTIVE OFFICER, DIRECTOR
TILLMAN 
GERNGROSS 
EXECUTIVE OFFICER, DIRECTOR
TILLMAN 
U. 
GERNGROSS 
EXECUTIVE OFFICER, DIRECTOR
DAVID 
 
KIRSKE 
EXECUTIVE OFFICER
DAVID 
 
MANTUS 
EXECUTIVE OFFICER
DAVID 
 
MCGIRR 
DIRECTOR
DEREK 
 
MEISNER 
EXECUTIVE OFFICER
ADAM 
 
MOSTAFA 
EXECUTIVE OFFICER
ADAM 
S. 
MOSTAFA 
EXECUTIVE OFFICER
ESZTER 
 
NAGY 
EXECUTIVE OFFICER, DIRECTOR
CLAUDIO 
 
NESSI 
DIRECTOR
PAULA 
 
RAGAN 
EXECUTIVE OFFICER, DIRECTOR
RENE 
 
RUSSO 
EXECUTIVE OFFICER, DIRECTOR
CHRIS 
 
STEVENS 
EXECUTIVE OFFICER
MURRAY 
 
STEWART 
EXECUTIVE OFFICER, DIRECTOR
MURRAY 
W. 
STEWART 
DIRECTOR
ARTHUR 
 
TAVERAS 
EXECUTIVE OFFICER
JOHN 
 
VOLPONE 
EXECUTIVE OFFICER
MICHAEL 
S. 
WYZGA 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2025-08-13 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2023-05-18 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2022-07-06 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2017-11-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-04-24 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2016-04-12 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-12-16 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-01-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-09-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
STIFEL, NICOLAUS + COMPANY, INCORPORATED
793
NONE
NONE
STIFEL, NICOLAUS + COMPANY, INC.
793
NONE
NONE
PIPER SANDLER + CO.
665
NONE
NONE
CANTOR FITZGERALD + CO.
134
NONE
NONE
CITIGROUP GLOBAL MARKETS INC.
NONE
NONE
COWEN AND COMPANY, LLC
NONE
NONE
PIPER JAFFRAY + CO.
665